Serum matrix metalloproteinase‐9 is elevated in men with a history of myocardial infarction

Autor: Anne Kalela, Matti Höyhtyä, Jaana Renko, O. Jaakkola, H. Alho, Seppo T. Nikkari, Seppo Laine
Rok vydání: 2004
Předmět:
Male
Clinical Biochemistry
Myocardial Infarction
030204 cardiovascular system & hematology
Lipoproteins
LDL/immunology

Logistic regression
Body Mass Index
chemistry.chemical_compound
0302 clinical medicine
Myocardial infarction
Complement C3/analysis
Finland
2. Zero hunger
Cholesterol
HDL/blood

Statistics
Smoking
Complement C3
General Medicine
Middle Aged
Lipoproteins
LDL

Triglycerides/blood
C-Reactive Protein
Cholesterol
Matrix Metalloproteinase 9
HDL/blood
LDL/immunology
lipids (amino acids
peptides
and proteins)

Matrix Metalloproteinase 9/blood
medicine.medical_specialty
Lipoproteins
Cholesterol/blood
Statistics
Nonparametric

C-Reactive Protein/analysis
03 medical and health sciences
Internal medicine
medicine
Humans
Nonparametric
Triglycerides
Autoantibodies
Aged
Triglyceride
business.industry
Cholesterol
HDL

Autoantibody
medicine.disease
Coronary heart disease
Cross-Sectional Studies
Logistic Models
Endocrinology
chemistry
Autoantibodies/blood
Myocardial Infarction/blood
business
Body mass index
030217 neurology & neurosurgery
Lipoprotein
Zdroj: Renko, J, Kalela, A, Jaakkola, O, Laine, S, Höyhtyä, M, Alho, H & Nikkari, S T 2004, ' Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction ', Scandinavian Journal of Clinical and Laboratory Investigation, vol. 64, no. 3, pp. 255-261 . https://doi.org/10.1080/00365510410006054
ISSN: 1502-7686
0036-5513
DOI: 10.1080/00365510410006054
Popis: Elevated serum inflammatory markers have been reported in coronary heart disease. Levels of serum matrix metalloproteinase‐9 (MMP‐9), C‐reactive protein (CRP), C3‐complement (C3) and autoantibodies against oxidized low‐density lipoprotein (oxLDL) in 120 male subjects with a history of myocardial infarction (MI) were compared with those in 250 age‐matched controls, both groups from a large cross‐sectional population survey, the FINRISK study. The concentrations of serum MMP‐9 and autoantibodies against oxLDL were measured by enzyme‐linked immunosorbent assay, CRP and C3 by immunonephelometry. MMP‐9, CRP and C3 concentrations were higher in the subjects with a history of MI than in the controls (p=0.037, p=0.004, and p=0.006, respectively). There was no difference between the groups in serum levels of autoantibodies against oxLDL. In other background characteristics, men in the MI group had higher body mass index (BMI) and serum triglyceride values and lower serum HDL cholesterol values compared to controls (p=0.009, p=0.001, and p
Databáze: OpenAIRE